- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0031634

About Libramed Pharmaceuticals Private Limited
Data last updated:
Libramed Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52599TG2019PTC132443. Its GSTIN is 36AADCL9157B1ZJ (Telangana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Mahendhar Punnam and Bharath Gajula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.63 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹12.24 Lakh (net margin 2.6%) and EBITDA of ₹62.89 Lakh (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 45% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹76.13 Lakh on record.
Libramed Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0031634). For more details, the company can be reached via its website libramed.in.
Company details
Recognitions & Rankings of Libramed Pharmaceuticals
Contact details
Libramed Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is libramed.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address13 – 198/16/Klr/2/96 & 97/E, Njr & Klr Nagar Phase 2 Block C Road No.1, Hyderabad, Telangana, India – 501401
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Libramed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Libramed Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Libramed Pharmaceuticals Private Limited, buy the company report.
Financials of Libramed Pharmaceuticals Private Limited
FY 2024 filings availableLibramed Pharmaceuticals Private Limited reported revenue of ₹4.63 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 2% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Libramed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Libramed Pharmaceuticals Private Limited
Libramed Pharmaceuticals has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendhar Punnam | Director | 01 May 2019 | 7 Years 6 Months | Current |
| Bharath Gajula | Director | 21 Oct 2022 | 4 Years 0 Months | Current |
| Latha Sri Bura | Director | 21 Oct 2022 | 4 Years 0 Months | Current |
| Pannala Mahipal Reddy | Director | 26 Jul 2019 | 7 Years 3 Months | Current |
| Balakrishna Dyavanapelly | Director | 01 May 2019 | 7 Years 6 Months | Current |
Auditor
Libramed Pharmaceuticals Private Limited is audited by Venkata Sai Krishna & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Venkata Sai Krishna & Co. | FY 2023 | 022488S |
Shareholding
The shareholding of Libramed Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Libramed Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2023 | 100848219 | Others | ₹76.13 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Libramed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Libramed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Libramed Pharmaceuticals Private Limited has a workforce of 18 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 18 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Libramed Pharmaceuticals Private Limited, buy the company report.
GST
Libramed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL9157B1ZJ | Telangana | Active | 20 Jun 2019 |
To see the full GST registrations and return filing status of Libramed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Libramed Pharmaceuticals Private Limited has 12 board changes on record since 2019: 5 appointments and 7 cessations. The latest: Naresh Babu Gundluru ceased to be Additional Director on 28 Oct 2024.
4 earlier events are in the company report.
Frequently asked questions
Libramed Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 May 2019 (7+ years old) and is registered under CIN U52599TG2019PTC132443.
Libramed Pharmaceuticals has 5 current directors:
- Mahendhar Punnam - Director
- Bharath Gajula - Director
- Latha Sri Bura - Director
- Pannala Mahipal Reddy - Director
- Balakrishna Dyavanapelly - Director
The latest financial statements of Libramed Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Libramed Pharmaceuticals is 36AADCL9157B1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Libramed Pharmaceuticals is U52599TG2019PTC132443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Libramed Pharmaceuticals was incorporated on 01 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Naresh Babu Gundluru ceased to be Additional Director on 28 Oct 2024. Vijayalakshmi ceased to be Director on 28 Oct 2024. Shailaja Cheruku ceased to be Director on 07 Jan 2023. Libramed Pharmaceuticals has 12 board changes on record in total.
Yes, Libramed Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0031634).
Libramed Pharmaceuticals can be reached through the website libramed.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Libramed Pharmaceuticals is at 13 – 19816Klr296 & 97E, Njr & Klr Nagar Phase 2 Block C Road No.1, Hyderabad, Telangana, India – 501401.

